Post-translational regulation of the β-secretase BACE1

Brain Research Bulletin

Volumn 126, Issue , 2016, Pages 170-177

  Araki, Wataru ^a  

^a NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

Author keywords

Alzheimer's disease; Amyloid protein; BACE1; Oligomer; Trafficking; Secretase

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PROTEIN; BETA SECRETASE 1; MEMBRANE PROTEIN; SECRETASE;

CELL MIGRATION; CELL SELECTION; ENDOCYTOSIS; ENDOSOME; ENZYME DEGRADATION; ENZYME GLYCOSYLATION; ENZYME PHOSPHORYLATION; ENZYME REGULATION; HUMAN; INTRACELLULAR TRANSPORT; LYSOSOME; NONHUMAN; PALMITOYLATION; PHYSIOLOGICAL PROCESS; PRIORITY JOURNAL; PROTEIN ACETYLATION; PROTEIN INTERACTION; PROTEIN PROCESSING; REVIEW; ANIMAL; GENE EXPRESSION REGULATION; METABOLISM;

AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; GENE EXPRESSION REGULATION; HUMANS; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 84997769494     PISSN: 03619230     EISSN: 18732747     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2016.04.009     Document Type: Review

References (122)

1. Araki, W., Tamaoka, A., Amyloid beta-protein and lipid rafts: focused on biogenesis and catabolism. Front. Biosci. (Landmark Ed.) 20 (2015), 314–324.
2. Araki, W., Oda, A., Motoki, K., Hattori, K., Itoh, M., Yuasa, S., Konishi, Y., Shin, R.W., Tamaoka, A., Ogino, K., Reduction of β−amyloid accumulation by reticulon 3 in transgenic mice. Curr. Alzheimer Res. 10 (2013), 135–142.
3. Benjannet, S., Elagoz, A., Wickham, L., Mamarbachi, M., Munzer, J.S., Basak, A., Lazure, C., Cromlish, J.A., Sisodia, S., Checler, F., Chrétien, M., Seidah, N.G., Post-translational processing of beta-secretase (beta-amyloid-converting enzyme) and its ectodomain shedding. The pro- and transmembrane/cytosolic domains affect its cellular activity and amyloid-beta production. J. Biol. Chem. 276 (2001), 10879–10887.
4. Bennett, B.D., Babu-Khan, S., Loeloff, R., Louis, J.C., Curran, E., Citron, M., Vassar, R., Expression analysis of BACE2 in brain and peripheral tissues. J. Biol. Chem. 275 (2000), 20647–20651.
5. Brunholz, S., Sisodia, S., Lorenzo, A., Deyts, C., Kins, S., Morfini, G., Axonal transport of APP and the spatial regulation of APP cleavage and function in neuronal cells. Exp. Brain Res. 217 (2012), 353–364.
6. Buggia-Prévot, V., Fernandez, C.G., Udayar, V., Vetrivel, K.S., Elie, A., Roseman, J., et al. A function for EHD family proteins in unidirectional retrograde dendritic transport of BACE1 and Alzheimer's disease Aβ production. Cell Rep. 5 (2013), 1552–1563.
7. Buggia-Prévot, V., Fernandez, C.G., Riordan, S., Vetrivel, K.S., Roseman, J., Waters, J., Bindokas, V.P., Vassar, R., Thinakaran, G., Axonal BACE1 dynamics and targeting in hippocampal neurons: a role for Rab11 GTPase. Mol. Neurodegener., 9, 2014, 1.
8. Cai, Q., Sheng, Z.H., Uncovering the role of Snapin in regulating autophagy-lysosomal function. Autophagy 7 (2011), 445–447.
9. Cai, H., Wang, Y., McCarthy, D., Wen, H., Borchelt, D.R., Price, D.L., Wong, P.C., BACE1 is the major beta-secretase for generation of Abeta peptides by neurons. Nat. Neurosci. 4 (2001), 233–234.
10. Capell, A., Steiner, H., Willem, M., Kaiser, H., Meyer, C., Walter, J., Lammich, S., Multhaup, G., Haass, C., Maturation and pro-peptide cleavage of beta-secretase. J. Biol. Chem. 275 (2000), 30849–30854.
11. Chami, L., Checler, F., BACE1 is at the crossroad of a toxic vicious cycle involving cellular stress and β-amyloid production in Alzheimer's disease. Mol. Neurodegener., 7, 2012, 52.
12. Charollais, J., Van Der Goot, F.G., Palmitoylation of membrane proteins (Review). Mol. Memb. Biol. 26 (2009), 55–66.
13. Chia, P.Z., Toh, W.H., Sharples, R., Gasnereau, I., Hill, A.F., Gleeson, P.A., Intracellular itinerary of internalised β-secretase BACE1, and its potential impact on β-amyloid peptide biogenesis. Traffic 14 (2013), 997–1013.
14. Chiurchiù, V., Maccarrone, M., Orlacchio, A., The role of reticulons in neurodegenerative diseases. Neuromolecular Med. 16 (2014), 3–15.
15. Cirrito, J.R., Yamada, K.A., Finn, M.B., Sloviter, R.S., Bales, K.R., May, P.C., Schoepp, D.D., Paul, S.M., Mennerick, S., Holtzman, D.M., Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo. Neuron 48 (2005), 913–922.
16. Costantini, C., Ko, M.H., Jonas, M.C., Puglielli, L., A reversible form of lysine acetylation in the ER and Golgi lumen controls the molecular stabilization of BACE1. Biochem. J 407 (2007), 383–395.
17. Das, U., Scott, D.A., Ganguly, A., Koo, E.H., Tang, Y., Roy, S., Activity-induced convergence of APP and BACE-1 in acidic microdomains via an endocytosis-dependent pathway. Neuron 79 (2013), 447–460.
18. Das, U., Wang, L., Ganguly, A., Saikia, J.M., Wagner, S.L., Koo, E.H., Roy, S., Visualizing APP and BACE-1 approximation in neurons yields insight into the amyloidogenic pathway. Nat. Neurosci. 19 (2016), 55–64.
19. De Strooper, B., Vassar, R., Golde, T., The secretases: enzymes with therapeutic potential in Alzheimer disease. Nat. Rev. Neurol. 6 (2010), 99–107.
20. Del Prete, D., Lombino, F., Liu, X., D'Adamio, L., APP is cleaved by Bace1 in pre-synaptic vesicles and establishes a pre-synaptic interactome, via its intracellular domain, with molecular complexes that regulate pre-synaptic vesicles functions. PLoS One, 9, 2014, e108576.
21. Deng, M., He, W., Tan, Y., Han, H., Hu, X., Xia, K., Zhang, Z., Yan, R., Increased expression of reticulon 3 in neurons leads to reduced axonal transport of β site amyloid precursor protein-cleaving enzyme 1. J. Biol. Chem. 288 (2013), 30236–30245.
22. Devi, L., Ohno, M., Phospho-eIF2α level is important for determining abilities of BACE1 reduction to rescue cholinergic neurodegeneration and memory defects in 5XFAD mice. PLoS One., 5, 2010, e12974.
23. Ding, Y., Ko, M.H., Pehar, M., Kotch, F., Peters, N.R., Luo, Y., Salamat, S.M., Puglielli, L., 2012 Biochemical inhibition of the acetyltransferases ATase1 and ATase2 reduces β-secretase (BACE1) levels and Aβ generation. J. Biol. Chem. 287 (2012), 8424–8433.
24. Ehehalt, R., Keller, P., Haass, C., Thiele, C., Simons, K., Amyloidogenic processing of the Alzheimer beta-amyloid precursor protein depends on lipid rafts. J. Cell Biol. 160 (2003), 113–123.
25. Farzan, M., Schnitzler, C.E., Vasilieva, N., Leung, D., Choe, H., BACE2, a beta-secretase homolog, cleaves at the beta site and within the amyloid-beta region of the amyloid-beta precursor protein. Proc. Natl. Acad. Sci. U.S.A. 97 (2000), 9712–9717.
26. Finan, G.M., Okada, H., Kim, T.W., BACE1 retrograde trafficking is uniquely regulated by the cytoplasmic domain of sortilin. J. Biol. Chem. 286 (2011), 12602–12616.
27. Fluhrer, R., Capell, A., Westmeyer, G., Willem, M., Hartung, B., Condron, M.M., Teplow, D.B., Haass, C., Walter, J., A non-amyloidogenic function of BACE-2 in the secretory pathway. J. Neurochem. 81 (2002), 1011–1020.
28. Fol, R., Braudeau, J., Ludewig, S., Abel, T., Weyer, S.W., Roederer, J.P., Brod, F., Audrain, M., Bemelmans, A.P., Buchholz, C.J., Korte, M., Cartier, N., Müller, U.C., Viral gene transfer of APPsα rescues synaptic failure in an Alzheimer's disease mouse model. Acta Neuropathol. 131 (2016), 247–266.
29. Fotinopoulou, A., Tsachaki, M., Vlavaki, M., Poulopoulos, A., Rostagno, A., Frangione, B., Ghiso, J., Efthimiopoulos, S., BRI2 interacts with amyloid precursor protein (APP) and regulates amyloid beta (Abeta) production. J. Biol. Chem. 280 (2005), 30768–30772.
30. Goldenring, J.R., Recycling endosomes. Curr. Opin. Cell Biol. 35 (2015), 117–122.
31. Gong, B., Chen, F., Pan, Y., Arrieta-Cruz, I., Yoshida, Y., Haroutunian, V., Pasinetti, G.M., SCFFbx2-E3-ligase-mediated degradation of BACE1 attenuates Alzheimer's disease amyloidosis and improves synaptic function. Aging Cell 9 (2010), 1018–1031.
32. Guglielmotto, M., Monteleone, D., Boido, M., Piras, A., Giliberto, L., Borghi, R., Vercelli, A., Fornaro, M., Tabaton, M., Tamagno, E., Aβ1-42-mediated down-regulation of Uch-L1 is dependent on NF-(B activation and impaired BACE1 lysosomal degradation. Aging Cell 11 (2012), 834–844.
33. Hampel, H., Shen, Y., Beta-site amyloid precursor protein cleaving enzyme 1 (BACE1) as a biological candidate marker of Alzheimer's disease. Scand. J. Clin. Lab. Invest. 69 (2009), 8–12.
34. Hardy, J., Selkoe, D.J., The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297 (2002), 353–356.
35. He, W., Lu, Y., Qahwash, I., Hu, X.Y., Chang, A., Yan, R., Reticulon family members modulate BACE1 activity and amyloid-beta peptide generation. Nat. Med. 10 (2004), 959–965.
36. He, X., Li, F., Chang, W.P., Tang, J., GGA proteins mediate the recycling pathway of memapsin 2 (BACE). J. Biol. Chem. 280 (2005), 11696–11703.
37. Hicks, D.A., Nalivaeva, N.N., Turner, A.J., Lipid rafts and Alzheimer's disease: protein-lipid interactions and perturbation of signaling. Front. Physiol., 3, 2012, 189.
38. Hu, X., Hicks, C.W., He, W., Wong, P., Macklin, W.B., Trapp, B.D., Yan, R., 2006 Bace1 modulates myelination in the central and peripheral nervous system. Nat. Neurosci. 9 (2016), 1520–1525.
39. Huse, J.T., Pijak, D.S., Leslie, G.J., Lee, V.M.-Y., Doms, R.W., Maturation and endosomal targeting of beta-site amyloid precursor protein-cleaving enzyme. The Alzheimer's disease beta-secretase. J. Biol. Chem. 275 (2000), 33729–33737.
40. John, B.A., Meister, M., Banning, A., Tikkanen, R., Flotillins bind to the dileucine sorting motif of β-site amyloid precursor protein-cleaving enzyme 1 and influence its endosomal sorting. FEBS J. 281 (2014), 2074–2087.
41. Kögel, D., Deller, T., Behl, C., Roles of amyloid precursor protein family members in neuroprotection, stress signaling and aging. Exp. Brain Res. 217 (2012), 471–479.
42. Kandalepas, P.C., Sadleir, K.R., Eimer, W.A., Zhao, J., Nicholson, D.A., Vassar, R., The Alzheimer's β-secretase BACE1 localizes to normal presynaptic terminals and to dystrophic presynaptic terminals surrounding amyloid plaques. Acta Neuropathol. 126 (2013), 329–352.
43. Kanekiyo, T., Bu, G., The low-density lipoprotein receptor-related protein 1 and amyloid-β clearance in Alzheimer's disease. Front. Aging Neurosci., 6, 2014, 93.
44. Kang, E.L., Cameron, A.N., Piazza, F., Walker, K.R., Tesco, G., Ubiquitin regulates GGA3-mediated degradation of BACE1. J. Biol. Chem. 285 (2010), 24108–24119.
45. Kang, E.L., Biscaro, B., Piazza, F., Tesco, G., BACE1 protein endocytosis and trafficking are differentially regulated by ubiquitination at lysine 501 and the Di-leucine motif in the carboxyl terminus. J. Biol. Chem. 287 (2012), 42867–42880.
46. Kimura, T., Ishiguro, K., Hisanaga, S., Physiological and pathological phosphorylation of tau by Cdk5. Front. Mol. Neurosci., 7, 2014, 65.
47. Kizuka, Y., Kitazume, S., Fujinawa, R., Saito, T., Iwata, N., Saido, T.C., Nakano, M., Yamaguchi, Y., Hashimoto, Y., Staufenbiel, M., Hatsuta, H., Murayama, S., Manya, H., Endo, T., Taniguchi, N., An aberrant sugar modification of BACE1 blocks its lysosomal targeting in Alzheimer's disease. EMBO Mol. Med. 7 (2015), 175–189.
48. Kizuka, Y., Nakano, M., Kitazume, S., Saito, T., Saido, T.C., Taniguchi, N., Bisecting GlcNAc modification stabilizes BACE1 protein under oxidative stress conditions. Biochem. J. 473 (2016), 21–30.
49. Ko, M.H., Puglielli, L., Two endoplasmic reticulum (ER)/ER Golgi intermediate compartment-based lysine acetyltransferases post-translationally regulate BACE1 levels. J. Biol. Chem. 284 (2009), 2482–2492.
50. Koh, Y.H., von Arnim, C.A., Hyman, B.T., Tanzi, R.E., Tesco, G.J., BACE is degraded via the lysosomal pathway. J. Biol. Chem. 280 (2005), 32499–32504.
51. Kume, H., Konishi, Y., Murayama, K.S., Kametani, F., Araki, W., Expression of reticulon 3 in Alzheimer's disease brain. Neuropathol. Appl. Neurobiol. 35 (2009), 178–188.
52. Kume, H., Murayama, K.S., Araki, W., The two-hydrophobic domain tertiary structure of reticulon proteins is critical for modulation of beta-secretase BACE1. J. Neurosci. Res. 87 (2009), 2963–2972.
53. Lazarov, O., Lee, M., Peterson, D.A., Sisodia, S.S., Evidence that synaptically released beta-amyloid accumulates as extracellular deposits in the hippocampus of transgenic mice. J. Neurosci. 22 (2002), 9785–9793.
54. Lefort, R., Pozueta, J., Shelanski, M., Cross-linking of cell surface amyloid precursor protein leads to increased β-amyloid peptide production in hippocampal neurons: implications for Alzheimer's disease. J. Neurosci. 32 (2012), 10674–10685.
55. Liang, B., Duan, B.Y., Zhou, X.P., Gong, J.X., Luo, Z.G., Calpain activation promotes BACE1 expression, amyloid precursor protein processing, and amyloid plaque formation in a transgenic mouse model of Alzheimer disease. J. Biol. Chem. 285 (2010), 27737–27744.
56. Lundgren, J.L., Ahmed, S., Schedin-Weiss, S., Gouras, G.K., Winblad, B., Tjernberg, L.O., Frykman, S., ADAM10 and BACE1 are localized to synaptic vesicles. J. Neurochem. 135 (2015), 606–615.
57. Luo, Y., Bolon, B., Kahn, S., Bennett, B.D., Babu-Khan, S., Denis, P., Fan, W., Kha, H., Zhang, J., Gong, Y., Martin, L., Louis, J.C., Yan, Q., Richards, W.G., Citron, M., Vassar, R., Mice deficient in BACE1, the Alzheimer's beta-secretase, have normal phenotype and abolished beta-amyloid generation. Nat. Neurosci. 4 (2001), 231–232.
58. Maesako, M., Uemura, M., Tashiro, Y., Sasaki, K., Watanabe, K., Noda, Y., Ueda, K., Asada-Utsugi, M., Kubota, M., Okawa, K., Ihara, M., Shimohama, S., Uemura, K., Kinoshita, A., High fat diet enhances β-site cleavage of amyloid precursor protein (APP) via promoting β-site APP cleaving enzyme 1/adaptor protein 2/clathrin complex formation. PLoS One, 10, 2015, e0131199.
59. Mamada, N., Tanokashira, D., Hosaka, A., Kametani, F., Tamaoka, A., Araki, W., Amyloid β-protein oligomers upregulate the β-secretase, BACE1, through a post-translational mechanism involving its altered subcellular distribution in neurons. Mol. Brain., 8, 2015, 73.
60. Mecozzi, V.J., Berman, D.E., Simoes, S., Vetanovetz, C., Awal, M.R., Patel, V.M., Schneider, R.T., Petsko, G.A., Ringe, D., Small, S.A., Pharmacological chaperones stabilize retromer to limit APP processing. Nat. Chem. Biol. 10 (2014), 443–449.
61. Medeiros, R., Kitazawa, M., Chabrier, M.A., Cheng, D., Baglietto-Vargas, D., Kling, A., Moeller, A., Green, K.N., LaFerla, F.M., Calpain inhibitor A-705253 mitigates Alzheimer's disease-like pathology and cognitive decline in aged 3xTgAD mice. Am. J. Pathol. 181 (2012), 616–625.
62. Miyagawa, T., Morohashi, Y., Ojima, R., Tsuji, S., Iwatsubo, T., Tomita, T., Bin1 regulates BACE1 trafficking and Ab production. Alzheimers Dement 10:Suppl (2014), 331–332.
63. Moreira, E.F., Jaworski, C.J., Rodriguez, I.R., Cloning of a novel member of the reticulon gene family (RTN3): gene structure and chromosomal localization to 11q13. Genomics 58 (1999), 73–81.
64. Motoki, K., Kume, H., Oda, A., Tamaoka, A., Hosaka, A., Kametani, F., Araki, W., Neuronal β-amyloid generation is independent of lipid raft association of β-secretase BACE1: analysis with a palmitoylation-deficient mutant. Brain Behav. 2 (2012), 270–282.
65. Murayama, K.S., Kametani, F., Saito, S., Kume, H., Akiyama, H., Araki, W., Reticulons RTN3 and RTN4-B/C interact with BACE1 and inhibit its ability to produce amyloid beta-protein. Eur. J. Neurosci. 24 (2006), 1237–1244.
66. O'Connor, T., Sadleir, K.R., Maus, E., Velliquette, R.A., Zhao, J., Cole, S.L., Eimer, W.A., Hitt, B., Bembinster, L.A., Lammich, S., Lichtenthaler, S.F., Hébert, S.S., De Strooper, B., Haass, C., Bennett, D.A., Vassar, R., Phosphorylation of the translation initiation factor eIF2alpha increases BACE1 levels and promotes amyloidogenesis. Neuron 60 (2008), 988–1009.
67. Obregon, D., Hou, H., Deng, J., Giunta, B., Tian, J., Darlington, D., Shahaduzzaman, M., Zhu, Y., Mori, T., Mattson, M.P., Tan, J., Soluble amyloid precursor protein-α modulates β-secretase activity and amyloid-β generation. Nat. Commun., 3, 2012, 777.
68. Ohno, M., Sametsky, E.A., Younkin, L.H., Oakley, H., Younkin, S.G., Citron, M., Vassar, R., Disterhoft, J.F., BACE1 deficiency rescues memory deficits and cholinergic dysfunction in a mouse model of Alzheimer's disease. Neuron 41 (2004), 27–33.
69. Okada, H., Zhang, W., Peterhoff, C., Hwang, J.C., Nixon, R.A., Ryu, S.H., Kim, T.W., Proteomic identification of sorting nexin 6 as a negative regulator of BACE1-mediated APP processing. FASEB J. 24 (2010), 2783–2794.
70. Pastorino, L., Ikin, A.F., Nairn, A.C., Pursnani, A., Buxbaum, J.D., The carboxyl-terminus of BACE contains a sorting signal that regulates BACE trafficking but not the formation of total A(beta). Mol. Cell. Neurosci. 19 (2002), 175–185.
71. Peters-Libeu, C., Campagna, J., Mitsumori, M., Poksay, K.S., Spilman, P., Sabogal, A., Bredesen, D.E., John, V., sAβPPα is a potent endogenous inhibitor of BACE1. J. Alzheimers Dis. 47 (2015), 545–555.
72. Pliássova, A., Lopes, J.P., Lemos, C., Oliveira, C.R., Cunha, R.A., Agostinho, P., The association of amyloid-β protein precursor with α- and β-secretases in mouse cerebral cortex synapses is altered in early Alzheimer's disease. Mol. Neurobiol., 2015.
73. Prabhu, Y., Burgos, P.V., Schindler, C., Farías, G.G., Magadán, J.G., Bonifacino, J.S., Adaptor protein 2-mediated endocytosis of the β-secretase BACE1 is dispensable for amyloid precursor protein processing. Mol. Biol. Cell 23 (2012), 2339–2351.
74. Qing, H., Zhou, W., Christensen, M.A., Sun, X., Tong, Y., Song, W., Degradation of BACE by the ubiquitin-proteasome pathway. FASEB J. 18 (2004), 1571–1573.
75. Riddell, D.R., Christie, G., Hussain, I., Dingwall, C., Compartmentalization of beta-secretase (Asp2) into low-buoyant density, noncaveolar lipid rafts. Curr. Biol. 11 (2001), 1288–1293.
76. Roberds, S.L., Anderson, J., Basi, G., Bienkowski, M.J., Branstetter, D.G., Chen, K.S., Freedman, S.B., Frigon, N.L., Games, D., Hu, K., Johnson-Wood, K., Kappenman, K.E., Kawabe, T.T., Kola, I., Kuehn, R., Lee, M., Liu, W., Motter, R., Nichols, N.F., Power, M., Robertson, D.W., Schenk, D., Schoor, M., Shopp, G.M., Shuck, M.E., Sinha, S., Svensson, K.A., Tatsuno, G., Tintrup, H., Wijsman, J., Wright, S., McConlogue, L., BACE knockout mice are healthy despite lacking the primary beta-secretase activity in brain: implications for Alzheimer's disease therapeutics. Hum. Mol. Genet. 10 (2001), 1317–1324.
77. Rossner, S., Sastre, M., Bourne, K., Lichtenthaler, S.F., Transcriptional and translational regulation of BACE1 expression–implications for Alzheimer's disease. Prog. Neurobiol. 79 (2006), 95–111.
78. Sadleir, K.R., Vassar, R., Cdk5 protein inhibition and Aβ42 increase BACE1 protein level in primary neurons by a post-transcriptional mechanism: implications of CDK5 as a therapeutic target for Alzheimer disease. J. Biol. Chem. 287 (2012), 7224–7235.
79. Sadleir, K.R., Eimer, W.A., Kaufman, R.J., Osten, P., Vassar, R., Genetic inhibition of phosphorylation of the translation initiation factor eIF2α does not block Aβ-dependent elevation of BACE1 and APP levels or reduce amyloid pathology in a mouse model of Alzheimer’ disease. PLoS One, 9, 2014, e101643.
80. Sannerud, R., Declerck, I., Peric, A., Raemaekers, T., Menendez, G., Zhou, L., Veerle, B., Coen, K., Munck, S., De Strooper, B., Schiavo, G., Annaert, W., ADP ribosylation factor 6 (ARF6) controls amyloid precursor protein (APP) processing by mediating the endosomal sorting of BACE1. Proc. Natl. Acad. Sci. U.S.A. 108 (2011), E559–568.
81. Shi, Q., Prior, M., He, W., Tang, X., Hu, X., Yan, R., Reduced amyloid deposition in mice overexpressing RTN3 is adversely affected by preformed dystrophic neurites. J. Neurosci. 29 (2009), 9163–9173.
82. Shi, Q., Ge, Y., Sharoar, M.G., He, W., Xiang, R., Zhang, Z., Hu, X., Yan, R., Impact of RTN3 deficiency on expression of BACE1 and amyloid deposition. J. Neurosci. 34 (2014), 13954–13962.
83. Sinha, S., Anderson, J.P., Barbour, R., Basi, G.S., Caccavello, R., Davis, D., Doan, M., Dovey, H.F., Frigon, N., Hong, J., Jacobson-Croak, K., Jewett, N., Keim, P., Knops, J., Lieberburg, I., Power, M., Tan, H., Tatsuno, G., Tung, J., Schenk, D., Seubert, P., Suomensaari, S.M., Wang, S., Walker, D., Zhao, J., McConlogue, L., John, V., Purification and cloning of amyloid precursor protein beta-secretase from human brain. Nature 402 (1999), 537–540.
84. Small, S.A., Petsko, G.A., Retromer in Alzheimer disease. Parkinson disease and other neurological disorders. Nat. Rev. Neurosci. 16 (2015), 126–132.
85. Song, W.J., Son, M.Y., Lee, H.W., Seo, H., Kim, J.H., Chung, S.H., Enhancement of BACE1 activity by p25/Cdk5-mediated phosphorylation in Alzheimer's Disease. PLoS One, 10, 2015, e0136950.
86. Sun, X., Bromley-Brits, K., Song, W., Regulation of β-site APP-cleaving enzyme 1 gene expression and its role in Alzheimer's disease. J. Neurochem. 120:Suppl. 1 (2012), 62–70.
87. Tamagno, E., Guglielmotto, M., Monteleone, D., Vercelli, A., Tabaton, M., Transcriptional and post-transcriptional regulation of β-secretase. IUBMB Life 64 (2012), 943–950.
88. Tan, J., Evin, G., Β-site APP-cleaving enzyme 1 trafficking and Alzheimer's disease pathogenesis. J. Neurochem. 120 (2012), 869–880.
89. Tan, M.S., Yu, J.T., Tan, L., Bridging integrator 1 (BIN1): form, function, and Alzheimer's disease. Trends Mol. Med. 19 (2013), 594–603.
90. Tanokashira, D., Motoki, K., Minegishi, S., Hosaka, A., Mamada, N., Tamaoka, A., Okada, T., Lakshmana, M.K., Araki, W., LRP1 downregulates the Alzheimer's β-secretase BACE1 by modulating its intraneuronal trafficking. Eneuro 2 (2015), e0006–0015.
91. Tesco, G., Koh, Y.H., Kang, E.L., Cameron, A.N., Das, S., Sena-Esteves, M., Hiltunen, M., Yang, S.H., Zhong, Z., Shen, Y., Simpkins, J.W., Tanzi, R.E., Depletion of GGA3 stabilizes BACE and enhances beta-secretase activity. Neuron 54 (2007), 721–737.
92. Tsachaki, M., Fotinopoulou, A., Slavi, N., Zarkou, V., Ghiso, J., Efthimiopoulos, S., BRI2 interacts with BACE1 and regulates its cellular levels by promoting its degradation and reducing its mRNA levels. Curr. Alzheimer Res. 10 (2013), 532–541.
93. Tseng, H.C., Zhou, Y., Shen, Y., Tsai, L.H., A survey of Cdk5 activator p35 and p25 levels in Alzheimer's disease brains. FEBS Lett. 523 (2002), 58–62.
94. Udayar, V., Buggia-Prévot, V., Guerreiro, R.L., Siegel, G., Rambabu, N., Soohoo, A.L., Ponnusamy, M., Siegenthaler, B., Bali, J., AESG, Simons, M., Ries, J., Puthenveedu, M.A., Hardy, J., Thinakaran, G., Rajendran, L., A paired RNAi and RabGAP overexpression screen identifies Rab11 as a regulator of -amyloid production. Cell Rep. 5 (2013), 1536–1551.
95. Vassar, R., Bennett, B.D., Babu-Khan, S., Kahn, S., Mendiaz, E.A., Denis, P., Teplow, D.B., Ross, S., Amarante, P., Loeloff, R., Luo, Y., Fisher, S., Fuller, J., Edenson, S., Lile, J., Jarosinski, M.A., Biere, A.L., Curran, E., Burgess, T., Louis, J.C., Collins, F., Treanor, J., Rogers, G., Citron, M., Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286 (1999), 735–741.
96. Vassar, R., Kuhn, P.H., Haass, C., Kennedy, M.E., Rajendran, L., Wong, P.C., Lichtenthaler, S.F., Function, therapeutic potential and cell biology of BACE proteases: current status and future prospects. J. Neurochem. 130 (2014), 4–28.
97. Vassar, R., BACE1 inhibitor drugs in clinical trials for Alzheimer's disease. Alzheimers Res. Ther., 6, 2014, 89.
98. Vetrivel, K.S., Thinakaran, G., Membrane rafts in Alzheimer's disease beta-amyloid production. Biochim. Biophys. Acta 1801 (2010), 860–867.
99. Vetrivel, K.S., Meckler, X., Chen, Y., Nguyen, P.D., Seidah, N.G., Vassar, R., Wong, P.C., Fukata, M., Kounnas, M.Z., Thinakaran, G., Alzheimer disease Abeta production in the absence of S-palmitoylation-dependent targeting of BACE1 to lipid rafts. J. Biol. Chem. 284 (2009), 3793–3803.
100. Viola, K.L., Klein, W.L., Amyloid β oligomers in Alzheimer's disease pathogenesis, treatment, and diagnosis. Acta Neuropathol. 129 (2015), 183–206.
101. von Arnim, C.A., Tangredi, M.M., Peltan, I.D., Lee, B.M., Irizarry, M.C., Kinoshita, A., Hyman, B.T., Demonstration of BACE (beta-secretase) phosphorylation and its interaction with GGA1 in cells by fluorescence-lifetime imaging microscopy. J. Cell Sci. 117 (2004), 5437–5445.
102. Wahle, T., Prager, K., Raffler, N., Haass, C., Famulok, M., Walter, J., GGA proteins regulate retrograde transport of BACE1 from endosomes to the trans-Golgi network. Mol. Cell. Neurosci. 29 (2005), 453–461.
103. Walker, K.R., Kang, E.L., Whalen, M.J., Shen, Y., Tesco, G., Depletion of GGA1 and GGA3 mediates postinjury elevation of BACE1. J. Neurosci. 32 (2012), 10423–10437.
104. Walter, J., Fluhrer, R., Hartung, B., Willem, M., Kaether, C., Capell, A., Lammich, S., Multhaup, G., Haass, C., Phosphorylation regulates intracellular trafficking of beta-secretase. J. Biol. Chem. 276 (2001), 14634–14641.
105. Wang, C.L., Tang, F.L., Peng, Y., Shen, C.Y., Mei, L., Xiong, W.C., VPS35 regulates developing mouse hippocampal neuronal morphogenesis by promoting retrograde trafficking of BACE1. Biol. Open 1 (2012), 1248–1257.
106. Wang, H., Li, R., Shen, Y., β-Secretase: its biology as a therapeutic target in diseasesβ-Secretase: its biology as a therapeutic target in diseases. Trends Pharmacol. Sci. 34 (2013), 215–225.
107. Wen, Y., Yu, W.H., Maloney, B., Bailey, J., Ma, J., Marié, I., Maurin, T., Wang, L., Figueroa, H., Herman, M., Krishnamurthy, P., Liu, L., Planel, E., Lau, L.F., Lahiri, D.K., Duff, K., Transcriptional regulation of beta-secretase by p25/cdk5 leads to enhanced amyloidogenic processing. Neuron 57 (2008), 680–690.
108. Wen, L., Tang, F.L., Hong, Y., Luo, S.W., Wang, C.L., He, W., Shen, C., Jung, J.U., Xiong, F., Lee, D.H., Zhang, Q.G., Brann, D., Kim, T.W., Yan, R., Mei, L., Xiong, W.C., VPS35 haploinsufficiency increases Alzheimer's disease neuropathology. J. Cell Biol. 195 (2011), 765–779.
109. Willem, M., Garratt, A.N., Novak, B., Citron, M., Kaufmann, S., Rittger, A., DeStrooper, B., Saftig, P., Birchmeier, C., Haass, C., Control of peripheral nerve myelination by the beta-secretase BACE1. Science 314 (2006), 664–666.
110. Wong, H.K., Sakurai, T., Oyama, F., Kaneko, K., Wada, K., Miyazaki, H., Kurosawa, M., De Strooper, B., Saftig, P., Nukina, N., beta Subunits of voltage-gated sodium channels are novel substrates of beta-site amyloid precursor protein-cleaving enzyme (BACE1) and gamma-secretase. J. Biol. Chem. 280 (2005), 23009–23017.
111. Yan, R., Bienkowski, M.J., Shuck, M.E., Miao, H., Tory, M.C., Pauley, A.M., Brashier, J.R., Stratman, N.C., Mathews, W.R., Buhl, A.E., Carter, D.B., Tomasselli, A.G., Parodi, L.A., Heinrikson, R.L., Gurney, M.E., Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity. Nature 402 (1999), 533–537.
112. Yan, R., Munzner, J.B., Shuck, M.E., Bienkowski, M.J., BACE2 functions as an alternative alpha-secretase in cells. J. Biol. Chem. 276 (2001), 34019–34027.
113. Ye, X., Cai, Q., Snapin-mediated BACE1 retrograde transport is essential for its degradation in lysosomes and regulation of APP processing in neurons. Cell Rep. 6 (2014), 24–31.
114. Zhang, X.M., Cai, Y., Xiong, K., Cai, H., Luo, X.G., Feng, J.C., Clough, R.W., Struble, R.G., Patrylo, P.R., Yan, X.X., Beta-secretase-1 elevation in transgenic mouse models of Alzheimer's disease is associated with synaptic/axonal pathology and amyloidogenesis: implications for neuritic plaque development. Eur. J. Neurosci. 30 (2009), 2271–2283.
115. Zhang, M., Deng, Y., Luo, Y., Zhang, S., Zou, H., Cai, F., Wada, K., Song, W., Control of BACE1 degradation and APP processing by ubiquitin carboxyl-terminal hydrolase L1. J. Neurochem. 120 (2012), 1129–1138.
116. Zhang, M., Cai, F., Zhang, S., Zhang, S., Song, W., Overexpression of ubiquitin carboxyl-terminal hydrolase L1 (UCHL1) delays Alzheimer's progression in vivo. Sci. Rep., 4, 2014, 7298.
117. Zhao, J., Fu, Y., Yasvoina, M., Shao, P., Hitt, B., O'Connor, T., Logan, S., Maus, E., Citron, M., Berry, R., Binder, L., Vassar, R., Beta-site amyloid precursor protein cleaving enzyme 1 levels become elevated in neurons around amyloid plaques: implications for Alzheimer's disease pathogenesis. J. Neurosci. 27 (2007), 3639–3649.
118. Zhao, Y., Wang, Y., Yang, J., Wang, X., Zha, Y., Zhang, X., Zhang, Y.W., Sorting nexin 12 interacts with BACE1 and regulates BACE1-mediated APP processing. Mol. Neurodegener., 7, 2012, 30.
119. Zhao, Y., Wang, Y., Hu, J., Zhang, X., Zhang, Y.W., CutA divalent cation tolerance homolog (Escherichia coli) (CUTA) regulates β-cleavage of β-amyloid precursor protein (APP) through interacting with β-site APP cleaving protein 1 (BACE1). J. Biol. Chem. 287 (2012), 11141–11150.
120. Zhi, P., Chia, P.Z., Gleeson, P.A., Intracellular trafficking of the β-secretase and processing of amyloid precursor protein. IUBMB Life 63 (2011), 721–729.
121. Zhou, L., Barão, S., Laga, M., Bockstael, K., Borgers, M., Gijsen, H., Annaert, W., Moechars, D., Mercken, M., Gevaert, K., De Strooper, B., The neural cell adhesion molecules L1 and CHL1 are cleaved by BACE1 protease in vivo. J. Biol. Chem. 287 (2012), 25927–25940.
122. Zhu, L., Su, M., Lucast, L., Liu, L., Netzer, W.J., Gandy, S.E., Cai, D., Dynamin 1 regulates amyloid generation through modulation of BACE-1. PLoS One, 7, 2012, e45033.